Home > Healthcare > Biotechnology > Biotechnology R&D > CRISPR and Cas Gene Market

CRISPR and Cas Gene Market Trends

Report ID: GMI6286
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

CRISPR and Cas Gene Market Trends

The increasing prevalence of cancer worldwide is anticipated to boost the industry evolution. For instance, according to the American Cancer Society, Inc. report, in 2022, there approximately more than 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the U.S. alone. Therefore, CRISPR-Cas gene editing technology offers a promising approach in the fight against cancer by enabling precise and customizable alterations to the genetic makeup of cancer cells. Moreover, ongoing advancements in gene editing techniques and a deeper understanding of cancer genetics will accelerate the adoption of CRISPR technology.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

CRISPR and cas gene market size was USD 2.5 billion in 2022 and will reach USD 17.4 billion by end of 2032 due to high prevalence of genetic diseases and complex medical conditions worldwide

The genome engineering application segment recorded 38.5% of the market share in 2022 driven by the rise in R&D activities demonstrating the effectiveness of CRISPR technologies

Biotechnology & pharmaceutical companies is projected to observe 21.2% CAGR from 2023-2032 owing to the rising number of partnerships and collaborations between academic researchers and industry players

North America accounted for 42.3% share of the market in 2022 and is anticipated to foresee considerable growth through 2032 owing to the presence of well-established biotechnology and pharmaceutical sector in the region